Filter results by
Evidence type
- Guidance and Policy (3836)
- Guidance (65)
- Policy and Strategy (10)
- Quality Indicators (66)
- Prescribing and Technical Information (3696)
- Secondary Evidence (8110)
- Systematic Reviews (7848)
- Evidence Summaries (129)
- Health Technology Assessments (133)
- Primary Research (23)
- Ongoing Trials (2702)
- Practice Based Information (31)
- Audit and Inspection Reports (26)
- Case Studies (5)
- Implementation Support (7)
- Information for the Public (523)
Source
Accredited
- All Wales Medicines Strategy Group - AWMSG (1000)
- American Society of Clinical Oncology (1)
- British Association of Dermatologists - BAD (1)
- British National Formulary - BNF (5040)
- British Society for Allergy and Clinical Immunology - BSACI (1)
- Centre for Reviews and Dissemination Health Technology Assessments - CRD HTA (5505)
- Department of Health (1)
- electronic Medicines Compendium - eMC (9546)
- EUnetHTA (30)
- European Medicines Agency - EMA (2125)
- Faculty of Sexual and Reproductive Healthcare (8)
- GOV UK (676)
- Medicines and Healthcare products Regulatory Agency - MHRA (675)
- Medicines Management Collection (1)
- National Institute for Health and Care Excellence - NICE (161)
- NHS England (4)
- NIHR Journals Library - Health Technology Assessment (1051)
- PrescQIPP (103)
- Public Health England - PHE (6)
- Scottish Dental Clinical Effectiveness Programme (1)
- Scottish Medicines Consortium - SMC (1597)
- Specialist Pharmacy Service (2069)
- US Food and Drug Administration - FDA (593)
- Welsh Medicines Resource Centre - WeMeReC (29)
